181 related articles for article (PubMed ID: 26030389)
1. Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence.
Johnson LA
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):6-30. PubMed ID: 26030389
[TBL] [Abstract][Full Text] [Related]
2. Assessment and measurement of medication adherence: oral agents for cancer.
Spoelstra SL; Rittenberg CN
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):47-52. PubMed ID: 26030393
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors: A Qualitative Study.
Verbrugghe M; Duprez V; Beeckman D; Grypdonck M; Quaghebeur M; Verschueren C; Verhaeghe S; Van Hecke A
Cancer Nurs; 2016; 39(2):153-62. PubMed ID: 25815430
[TBL] [Abstract][Full Text] [Related]
4. Theoretical foundations of adherence behaviors: synthesis and application in adherence to oral oncology agents.
Irwin M
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):31-5. PubMed ID: 26030390
[TBL] [Abstract][Full Text] [Related]
5. Overview of the challenges related to oral agents for cancer and their impact on adherence.
Tipton JM
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):37-40. PubMed ID: 26030391
[TBL] [Abstract][Full Text] [Related]
6. Improving adherence to oral cancer therapy in clinical practice.
McCue DA; Lohr LK; Pick AM
Pharmacotherapy; 2014 May; 34(5):481-94. PubMed ID: 24877187
[TBL] [Abstract][Full Text] [Related]
7. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.
Verbrugghe M; Verhaeghe S; Lauwaert K; Beeckman D; Van Hecke A
Cancer Treat Rev; 2013 Oct; 39(6):610-21. PubMed ID: 23428230
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population.
Watson CH; Fish LJ; Falkovic M; Monuszko K; Lorenzo A; Havrilesky LJ; Secord AA; Davidson BA
Obstet Gynecol; 2020 Dec; 136(6):1145-1153. PubMed ID: 33156183
[TBL] [Abstract][Full Text] [Related]
9. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
10. Putting evidence into practice: evidence-based interventions for oral agents for cancer.
Spoelstra SL; Sansoucie H
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):60-72. PubMed ID: 26030394
[TBL] [Abstract][Full Text] [Related]
11. Using tools and technology to promote education and adherence to oral agents for cancer.
Burhenn PS; Smudde J
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):53-9. PubMed ID: 26030395
[TBL] [Abstract][Full Text] [Related]
12. Driving and Disabling Factors of Noncurative Oral Chemotherapy Adherence: A Qualitative Evidence Synthesis.
Dowling M; Hunter A; Biesty L; Meskell P; Conway A; O'Boyle G; Morrissey E; Houghton C
Oncol Nurs Forum; 2019 Jan; 46(1):16-28. PubMed ID: 30547955
[TBL] [Abstract][Full Text] [Related]
13. Adherence and patients' experiences with the use of oral anticancer agents.
Timmers L; Boons CC; Kropff F; van de Ven PM; Swart EL; Smit EF; Zweegman S; Kroep JR; Timmer-Bonte JN; Boven E; Hugtenburg JG
Acta Oncol; 2014 Feb; 53(2):259-67. PubMed ID: 24266637
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of the feasibility and preliminary efficacy of a texting intervention on medication adherence in adults prescribed oral anti-cancer agents: study protocol.
Spoelstra SL; Given CW; Sikorskii A; Coursaris CK; Majumder A; DeKoekkoek T; Schueller M; Given BA
J Adv Nurs; 2015 Dec; 71(12):2965-76. PubMed ID: 26100719
[TBL] [Abstract][Full Text] [Related]
15. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
17. Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study.
Wu S; Chee D; Ugalde A; Butow P; Seymour J; Schofield P
Palliat Support Care; 2015 Apr; 13(2):255-63. PubMed ID: 24524212
[TBL] [Abstract][Full Text] [Related]
18. Oral agents for cancer: safety challenges and recommendations.
Rudnitzki T; McMahon D
Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):41-6. PubMed ID: 26030392
[TBL] [Abstract][Full Text] [Related]
19. Adherence influencing factors in patients taking oral anticancer agents: a systematic review.
Mathes T; Pieper D; Antoine SL; Eikermann M
Cancer Epidemiol; 2014 Jun; 38(3):214-26. PubMed ID: 24768601
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents.
Decker V; Spoelstra S; Miezo E; Bremer R; You M; Given C; Given B
Cancer Nurs; 2009; 32(6):E20-9. PubMed ID: 19816160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
